Shire Targets Mylan In Latest Suit Over Generic Vyvanse
Shire PLC sued Mylan Inc. on Thursday in New York over a planned generic version of the attention deficit hyperactivity disorder treatment Vyvanse, marking the company's latest effort to protect the...To view the full article, register now.
Already a subscriber? Click here to view full article